Ingenus: Dr Reddy's arm inks pact with Ingenus Pharma to market Cyclophosphamide Injection
Dr Reddy's Laboratories said that its wholly owned subsidiary, Dr. Reddy's USA and Ingenus Pharmaceuticals has entered into license agreement to commercialise Cyclophosphamide Injection RTD in United States (US).
Read full article »
Chairman & CEO
Raju Mantena
Ingenus develops and commercializes pharmaceutical dosage forms such as semi-solids, injectable, topical foams and sprays.
Read more